Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Discrete visual defects in pearl mutant mice.

Balkema GW, Mangini NJ, Pinto LH.

Science. 1983 Mar 4;219(4588):1085-7.

PMID:
6600521
2.

A naturally occurring mouse model of X-linked congenital stationary night blindness.

Pardue MT, McCall MA, LaVail MM, Gregg RG, Peachey NS.

Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2443-9.

PMID:
9804152
4.

Identification of the gene and the mutation responsible for the mouse nob phenotype.

Gregg RG, Mukhopadhyay S, Candille SI, Ball SL, Pardue MT, McCall MA, Peachey NS.

Invest Ophthalmol Vis Sci. 2003 Jan;44(1):378-84.

PMID:
12506099
5.

The beta3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness.

Feng L, Seymour AB, Jiang S, To A, Peden AA, Novak EK, Zhen L, Rusiniak ME, Eicher EM, Robinson MS, Gorin MB, Swank RT.

Hum Mol Genet. 1999 Feb;8(2):323-30.

PMID:
9931340
6.
7.

Characterization of abnormalities in the visual system of the mutant mouse pearl.

Balkema GW Jr, Pinto LH, Dräger UC, Vanable JW Jr.

J Neurosci. 1981 Nov;1(11):1320-9.

PMID:
7310489
8.
9.

The binding of somatostatin to the mouse retina is altered by the pearl mutation.

Kossut M, Aldrich LB, Yamada T, Pinto LH.

Brain Res. 1990 Jul 9;522(2):235-40.

PMID:
1977495
10.

Congenital stationary night blindness: an animal model.

Witzel DA, Smith EL, Wilson RD, Aguirre GD.

Invest Ophthalmol Vis Sci. 1978 Aug;17(8):788-95.

PMID:
308060
11.

Night blindness and the retinal mechanism of visual adaptation.

Ripps H.

Ann R Coll Surg Engl. 1976 May;58(3):222-32.

PMID:
1083707
12.

Phototransduction in a transgenic mouse model of Nougaret night blindness.

Moussaif M, Rubin WW, Kerov V, Reh R, Chen D, Lem J, Chen CK, Hurley JB, Burns ME, Artemyev NO.

J Neurosci. 2006 Jun 21;26(25):6863-72.

PMID:
16793893
13.

Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness.

Bech-Hansen NT, Naylor MJ, Maybaum TA, Sparkes RL, Koop B, Birch DG, Bergen AA, Prinsen CF, Polomeno RC, Gal A, Drack AV, Musarella MA, Jacobson SG, Young RS, Weleber RG.

Nat Genet. 2000 Nov;26(3):319-23.

PMID:
11062471
14.

Constitutive "light" adaptation in rods from G90D rhodopsin: a mechanism for human congenital nightblindness without rod cell loss.

Sieving PA, Fowler ML, Bush RA, Machida S, Calvert PD, Green DG, Makino CL, McHenry CL.

J Neurosci. 2001 Aug 1;21(15):5449-60.

PMID:
11466416
15.

Diagnosis in a patient with fundus albipunctatus and atypical fundus changes.

Hajali M, Fishman GA, Dryja TP, Sweeney MO, Lindeman M.

Doc Ophthalmol. 2009 Jun;118(3):233-8. doi: 10.1007/s10633-008-9151-8. Epub 2008 Oct 24.

PMID:
18949499
16.

A naturally-occurring mutation in Cacna1f in a rat model of congenital stationary night blindness.

Gu Y, Wang L, Zhou J, Guo Q, Liu N, Ding Z, Li L, Liu X, An J, Yan G, Yao L, Zhang Z.

Mol Vis. 2008 Jan 9;14:20-8.

PMID:
18246026
17.

A dominant form of inherited retinal degeneration caused by a non-photoreceptor cell-specific mutation.

Li L, Dowling JE.

Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11645-50.

PMID:
9326664
18.

Functional abnormalities in vincristine-induced night blindness.

Ripps H, Carr RE, Siegel IM, Greenstein VC.

Invest Ophthalmol Vis Sci. 1984 Jul;25(7):787-94.

PMID:
6329990
19.

Retinal degeneration 6 (rd6): a new mouse model for human retinitis punctata albescens.

Hawes NL, Chang B, Hageman GS, Nusinowitz S, Nishina PM, Schneider BS, Smith RS, Roderick TH, Davisson MT, Heckenlively JR.

Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3149-57.

PMID:
10967077
20.

An electrophysiological and psychophysical study of two forms of congenital night blindness.

Auerbach E, Godel V, Rowe H.

Invest Ophthalmol. 1969 Jun;8(3):332-45. No abstract available.

PMID:
4306337

Supplemental Content

Support Center